CurveBeam AI Limited (ASX:CVB)

Market Cap	35.91M
Revenue (ttm)	7.91M
Net Income (ttm)	-19.45M
Shares Out	390.27M
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,700
Average Volume	49,139
Open	0.0970
Previous Close	0.0970
Day's Range	0.0950 - 0.0970
52-Week Range	0.0850 - 0.2900
Beta	n/a
RSI	39.55
Earnings Date	Apr 29, 2025

About CurveBeam AI

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe and North America. The company builds artificial intelligence tools to aid in bone separation and segmentation, empowering orthopedic surgeons to make 3D-based deformity measurements to inform clinical decisions. It is also involved in AI’s Deep Learning AI based platform aids in bone microstructure analysis. The company’s target customers include orthopedic practices, imaging centers, and hospitals. Cu...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 50
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CVB

Financial Performance

In 2024, CurveBeam AI's revenue was 6.53 million, a decrease of -18.97% compared to the previous year's 8.06 million. Losses were -23.10 million, -54.90% less than in 2023.